Investigating the Use of TGF-ß2 to Downregulate MHC Expression and Reduce the Immunogenicity of Equine Bone Marrow-derived Mesenchymal Stem Cells.

dc.contributor.advisorLauren Schnabel, Co-Chair
dc.contributor.advisorSamuel Jones, Co-Chair
dc.contributor.advisorJonathan Fogle, Member
dc.contributor.advisorKe Cheng, Member
dc.contributor.advisorMatthew Fisher, Member
dc.contributor.authorBerglund, Alix Kay
dc.date.accepted2018-03-09
dc.date.accessioned2018-04-06T12:33:23Z
dc.date.available2018-04-06T12:33:23Z
dc.date.defense2018-02-28
dc.date.issued2018-02-28
dc.date.released2018-04-06
dc.date.reviewed2018-03-02
dc.date.submitted2018-03-01
dc.degree.disciplineComparative Biomedical Sci
dc.degree.leveldissertation
dc.degree.nameDoctor of Philosophy
dc.identifier.otherdeg7971
dc.identifier.urihttp://www.lib.ncsu.edu/resolver/1840.20/35051
dc.rights
dc.titleInvestigating the Use of TGF-ß2 to Downregulate MHC Expression and Reduce the Immunogenicity of Equine Bone Marrow-derived Mesenchymal Stem Cells.

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
etd.pdf
Size:
2.84 MB
Format:
Adobe Portable Document Format

Collections